Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 2, 2016, Pages 191-202.e4

  Khan, Anam ^a   Tansel, Aylin ^b   White, Donna L ^a,b,d,e   Kayani, Waleed Tallat ^a   Bano, Shah ^c   Lindsay, Jan ^a,b   El Serag, Hashem B ^a,b,d   Kanwal, Fasiha ^a,b,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^d Dan L Duncan Cancer Center   (United States)

^e Center of Translational Research on Inflammatory Diseases   (United States)

Author keywords

Alcohol Abuse; Alcoholism; Cirrhosis; MET; Relapse Prevention

Indexed keywords

ALCOHOL ABSTINENCE; CHRONIC LIVER DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; COMPARATIVE STUDY; HEALTH CARE DELIVERY; HEALTH EDUCATION; HUMAN; INTERVENTION STUDY; MAINTENANCE THERAPY; MOTIVATIONAL ENHANCEMENT THERAPY; MOTIVATIONAL INTERVIEWING; OBSERVATIONAL STUDY; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUPPORTIVE THERAPY; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; TREATMENT RESPONSE; ALCOHOLISM; BEHAVIOR THERAPY; COMPLICATION; LIVER DISEASES; PROCEDURES; PSYCHOLOGY; PSYCHOSOCIAL REHABILITATION;

ALCOHOL ABSTINENCE; ALCOHOLISM; BEHAVIOR THERAPY; HUMANS; LIVER DISEASES; PSYCHIATRIC REHABILITATION; TREATMENT OUTCOME;

EID: 84958966475     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.07.047     Document Type: Review

References (36)

1. Rehm J., Samokhvalov A.V., Shield K.D. Global burden of alcoholic liver diseases. J Hepatol 2013, 59:160-168.
2. Blachier M., Leleu H., Peck-Radosavljevic M., et al. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013, 58:593-608.
3. Rehm J., Shield K.D., Rehm M.X., et al. Alcohol consumption, alcohol dependence, and attributable burden of disease in Europe: potential gains from effective interventions for alcohol dependence 2012, Centre for Addiction and Mental Health, Toronto, Canada.
4. Rehm J., Taylor B., Mohapatra S., et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010, 29:437-445.
5. Corrao G., Arico S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998, 27:914-919.
6. Minato T., Tsutsumi M., Tsuchishima M., et al. Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis. Mol Med 2014, 20:486-489.
7. Pessione F., Ramond M.J., Peters L., et al. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis: effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003, 23:45-53.
8. Younossi Z.M. Mortality risk greater among patients with HCV who drank alcohol moderately, heavily. Aliment Pharmacol Ther 2013, 37:703-709.
9. Jaurigue M.M., Cappell M.S. Therapy for alcoholic liver disease. World J Gastroenterol 2014, 20:2143-2158.
10. Kershenobich D., Corona D.L., Kershenovich R., et al. Management of alcoholic liver disease: an update. Alcohol Clin Exp Res 2011, 35:804-805.
11. Woo G.A., O'Brien C. Long-term management of alcoholic liver disease. Clin Liver Dis 2012, 16:763-781.
12. Vuittonet C.L., Halse M., Leggio L., et al. Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health-Syst Pharm 2014, 71:1265-1276.
13. Addolorato G., Leggio L., Ferrulli A., et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double blind controlled study. Lancet 2007, 370:1915.
14. Leggio L., Ferrulli A., Zambon A., et al. Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection. Addict Behav 2012, 37:561-564.
15. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. J Stud Alcohol 1998, 59:631-639. Project MATCH Research Group.
16. Miller W.R., Wilbourne P.L. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use. Addiction 2002, 97:265-277.
17. Willenbring M.L., Johnson S.B., Tan E. Characteristics of medical patients referred for treatment for alcoholism. J Subst Abuse Treat 1994, 11:259-265.
18. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
19. Higgins J.P., Altman D.G., Gøtzsche P.C., et al. Cochrane Statistical Methods Group: the Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928.
20. Downs S.H., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52:377-384.
21. Willenbring M.L., Olson D.H. A randomized trial of integrated outpatient treatment for medically ill alcoholic men. Arch Intern Med 1999, 159:1946-1952.
22. Dieperink E., Fuller B., Isenhart C., et al. Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial. Addiction 2014, 109:1869-1877.
23. Drumright L.N., Hagan H., Thomas D.L., et al. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. J Hepatol 2011, 55:45-52.
24. Weinrieb R.M., Van Horn D.H., Lynch K.G., et al. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl 2011, 17:539-547.
25. Kuchipudi V., Hobein K., Flickinger A., et al. Failure of a 2-hour motivational intervention to alter recurrent drinking behavior in alcoholics with gastrointestinal disease. J Stud Alcohol 1990, 51:356-360.
26. Andersen M.M., Aunt S., Jensen N.M., et al. Rehabilitation for cirrhotic patients discharged after hepatic encephalopathy improves survival. Dan Med J 2013, 60:A4683.
27. Addolorato G., Mirijello A., Leggio L. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res 2013, 37:1601-1608.
28. Proeschold-Bell R.J., Patkar A.A., Naggie S., et al. An integrated alcohol abuse and medical treatment model for patients with hepatitis C. Dig Dis Sci 2012, 57:1083-1091.
29. Dieperink E., Ho S.B., Heit S., et al. Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic. Psychosomatics 2010, 51:149-156.
30. Georgiou G., Webb K., Griggs K., et al. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl 2003, 9:772-775.
31. Erim Y., Beckmann M., Tagay S., et al. Stabilisation of abstinence by means of psychoeducation for patients with alcoholic liver disease awaiting liver transplantation. Z Psychosom Med Psychother 2006, 52:341-357.
32. Lieber C.S., Weiss D.G., Groszmann R., et al. I: Veterans Affairs cooperative study of polyenylphosphatidylcholine in alcoholic liver disease-effects on drinking behavior by nurse/physician teams. Alcohol Clin Exp Res 2003, 27:1757-1764.
33. Ink O., Dejonghe J.P., Hagege H., et al. Long-term outcome of alcoholic patients after a stay in a hospital hepatogastroenterology unit. Gastroenterol Clin Biol 1991, 15:620-628.
34. Burke B.L., Arkowitz H., Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consul Clin Psych 2003, 71:843.
35. Magill M., Ray L.A. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs 2009, 70:516.
36. Weisner C., Mertens J., Moore C., et al. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA 2001, 286:1715-1723.